Crossref
The Present Status of LAK Cell plus IL-2 Immunotherapy for Malignant Gliomas(What is the Best Treatment for Malignant Gliomas?)
Japanese Journal of Neurosurgery · 1992
DOI: 10.7887/jcns.1.110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Japanese Journal of Neurosurgery, 1992. Verfasst von Seiichi Yoshida und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yoshida, S., Tanaka, R., Takai, N., Ono, K., & Mori, H. (1992). The Present Status of LAK Cell plus IL-2 Immunotherapy for Malignant Gliomas(What is the Best Treatment for Malignant Gliomas?). Japanese Journal of Neurosurgery. https://doi.org/10.7887/jcns.1.110
Vancouver
Yoshida S, Tanaka R, Takai N, Ono K, Mori H. The Present Status of LAK Cell plus IL-2 Immunotherapy for Malignant Gliomas(What is the Best Treatment for Malignant Gliomas?). Japanese Journal of Neurosurgery. 1992. doi:10.7887/jcns.1.110
BibTeX
@article{Yoshida1992,
author = {Yoshida, Seiichi and Tanaka, Ryuichi and Takai, Nobuyuki and Ono, Koji and Mori, Hiroshi},
title = {The Present Status of LAK Cell plus IL-2 Immunotherapy for Malignant Gliomas(What is the Best Treatment for Malignant Gliomas?)},
journal = {Japanese Journal of Neurosurgery},
year = {1992},
doi = {10.7887/jcns.1.110}
}
EUVIMED